Here are three points:
1. Twelve Wall Street firms have rated the company’s stock as a “strong buy.”
2. Boston Scientific has a 52-week high of $23.35 and a 52-week low of $14.18.
3. The company’s market cap is $1.3 billion.
More articles on GI/endoscopy:
4 things to know about Healthmark’s Endoscope Cleaning Brush
5 most read GI/endoscopy stories: June 13 — June 17
Ohio Gastroenterology & Liver Institute incorporates HyGIeaCare Prep System: 3 points
